GSK announces breakthrough data showing RSV vaccine cuts hospitalizations in elderly
The data highlights its RSV vaccine cuts hospitalizations in older adults
The data highlights its RSV vaccine cuts hospitalizations in older adults
The therapy, also known as UM171 Cell Therapy, recently received conditional marketing authorization from the European Commission
mNEXSPIKE is the third Moderna vaccine authorized in the European Union, strengthening the Company's respiratory vaccine portfolio in Europe
The NIRSE-GAL study, conducted in Galicia, Spain, is the first real-world, population-based investigation of a universal RSV immunization program spanning two consecutive seasons
Revenue from operations rose to Rs. 23,637 million for the three months ended December 31, 2025
ATEC secures exclusive U.S. commercial rights to Theradaptive’s OsteoAdapt osteoinductive bone graft, currently in clinical trials for spinal and dental applications
NTX-253 is a potent, selective, orally available positive allosteric modulator (PAM) of the muscarinic M4 receptor
The Toumai platform, currently the only robotic system with US FDA Study Approval for telesurgery, enabled real-time surgical control with no compromise to patient safety
Subscribe To Our Newsletter & Stay Updated